[Basic studies on I-123-beta-methyl-p-iodophenylpentadecanoic acid (BMIPP) for myocardial functional diagnosis: effect of beta-oxidation inhibitor].
Fujibayashi
Y
Y
Yonekura
Y
Y
Kawai
K
K
Yamamoto
K
K
Tamaki
N
N
Konishi
J
J
Yokoyama
A
A
Torizuka
K
K
D000818:Animals; D002333:Carnitine Acyltransferases / Q000037:antagonists & inhibitors; D004852:Epoxy Compounds / Q000494:pharmacology*; D004988:Ethers, Cyclic / Q000494:pharmacology*; D005227:Fatty Acids / Q000378:metabolism / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D007457:Iodine Radioisotopes / Q000378:metabolism; D007462:Iodobenzenes / Q000378:metabolism; D008297:Male; D009206:Myocardium / Q000378:metabolism; D010084:Oxidation-Reduction / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D014280:Triglycerides / Q000096:biosynthesis
D004852:Epoxy Compounds; D004988:Ethers, Cyclic; D005227:Fatty Acids; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D014280:Triglycerides; C049338:iodofiltic acid; D002333:Carnitine Acyltransferases; C021756:2-tetradecylglycidic acid